Ovarian Reserve and AMH Interpretation

Definition

Ovarian reserve and AMH interpretation is the reproductive-data frame that uses anti-Mullerian hormone as an imperfect estimate of egg supply or likely stimulation response while separating that information from egg quality, embryo competence, age, and pregnancy probability.

Current Synthesis

The Crawford episode treats AMH as useful because it gives earlier visibility into ovarian reserve, but it resists overreading the number. AMH is not a direct egg-quality test; it is closer to a reserve and likely response signal. Egg quality remains harder to test directly and is discussed through age, genetic normalcy, mitochondrial competence, chromosome handling, and eventual embryo outcomes.

The practical value is planning literacy. Knowing reserve can help a patient decide whether to seek evaluation, consider egg freezing, interpret IVF expectations, or investigate ovulation disorders, but it should not be turned into a simple yes/no fertility prediction.

Key Claims

• Women are born with a finite egg supply that declines across fetal life, birth, first period, and reproductive adulthood.
• AMH is a simple but imperfect blood marker for ovarian reserve, not a direct test of egg quality.
• Egg quality is framed as genetic normalcy and egg competence, including mitochondrial function and chromosome handling.
• Age remains an imperfect proxy for egg quality because direct egg-quality testing is not available in ordinary preconception care.
• Low or unexpected AMH can support earlier reproductive planning, but interpretation should include age, cycle pattern, ovulation, medical history, and goals.
• AMH and ovulation tracking can complement each other when investigating irregular ovulation, short luteal phase, PCOS, thyroid issues, or prolactin concerns.

Evidence

• Finite supply - How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford gives the episode’s egg-supply arc from fetal life to birth to first period.
• AMH boundary - How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford defines AMH as an ovarian-reserve estimate rather than an egg-quality test.
• Egg-quality boundary - How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford says egg quality involves genetic normalcy, competence, mitochondrial function, and chromosome handling, with age used as an imperfect proxy.
• Ovulation context - How Women Can Improve Their Fertility & Hormone Health | Dr. Natalie Crawford recommends investigating prolactin, thyroid issues, AMH, and PCOS when ovulation patterns are abnormal.

Counterevidence & Qualifications

AMH can be useful and anxiety-provoking at the same time. The source does not make it a universal screening mandate, a direct natural-fertility probability, or a replacement for evaluation by reproductive endocrinology, OBGYN, endocrinology, or fertility specialists. Normal AMH does not guarantee egg quality, and low AMH does not by itself settle whether pregnancy is possible.

What Changed

• Created a dedicated AMH and ovarian-reserve page to prevent the broader fertility-health marker from conflating egg quantity, egg quality, and pregnancy odds.

Related Concepts

• Female Fertility as Health Marker - parent fertility-health signal frame.
• Assisted Reproduction Decision Literacy - downstream branch where reserve and egg quality shape IVF and egg-freezing expectations.
• Female Hormone Health Phenotyping - broader hormone-measurement context.
• Personal Health Data - longitudinal data frame for interpreting biomarkers over time.
• Medical Knowledge Boundary - uncertainty boundary for imperfect tests.
• PCOS Cardiometabolic Risk - related reproductive-endocrine condition where ovulation and metabolic markers interact.